Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexis A Borisy

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Nature Reviews. Drug Discovery|February 3, 2005
Multicomponent therapeutics for networked systemsCurtis T Keith, Alexis A Borisy, Brent R Stockwell
Discovery Medicine|December 31, 2009
Therapeutic selectivity and the multi-node drug targetJoseph Lehar, Andrew S Krueger, Grant R Zimmermann, et al.
Arthritis Research & Therapy|January 28, 2009
Selective amplification of glucocorticoid anti-inflammatory activity through synergistic multi-target action of a combination drugGrant R Zimmermann, William Avery, Alyce L Finelli, et al.
Cancer Research|December 7, 2007
The novel combination of chlorpromazine and pentamidine exerts synergistic antiproliferative effects through dual mitotic actionMargaret S Lee, Lisa Johansen, Yanzhen Zhang, et al.
Molecular Systems Biology|June 10, 2010
Chemical combinations elucidate pathway interactions and regulation relevant to Hepatitis C replicationChristopher M Owens, Christina Mawhinney, Jill M Grenier, et al.
Blood|April 13, 2010
Adenosine A2A receptor agonists and PDE inhibitors: a synergistic multitarget mechanism discovered through systematic combination screening in B-cell malignanciesRichard J Rickles, Laura T Pierce, Thomas P Giordano, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 12, 2003
Systematic discovery of multicomponent therapeuticsAlexis A Borisy, Peter J Elliott, Nicole W Hurst, et al.
Nature Biotechnology|July 8, 2009
Synergistic drug combinations tend to improve therapeutically relevant selectivityJoseph Lehár, Andrew S Krueger, William Avery, et al.
Molecular Systems Biology|March 3, 2007
Chemical combination effects predict connectivity in biological systemsJoseph Lehár, Grant R Zimmermann, Andrew S Krueger, et al.
Molecular Cancer Therapeutics|April 5, 2012
Adenosine A2A and beta-2 adrenergic receptor agonists: novel selective and synergistic multiple myeloma targets discovered through systematic combination screeningRichard J Rickles, Winnie F Tam, Thomas P Giordano, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Nature Reviews. Drug Discovery|February 3, 2005
Multicomponent therapeutics for networked systemsCurtis T Keith, Alexis A Borisy, Brent R Stockwell
Discovery Medicine|December 31, 2009
Therapeutic selectivity and the multi-node drug targetJoseph Lehar, Andrew S Krueger, Grant R Zimmermann, et al.
Arthritis Research & Therapy|January 28, 2009
Selective amplification of glucocorticoid anti-inflammatory activity through synergistic multi-target action of a combination drugGrant R Zimmermann, William Avery, Alyce L Finelli, et al.
Cancer Research|December 7, 2007
The novel combination of chlorpromazine and pentamidine exerts synergistic antiproliferative effects through dual mitotic actionMargaret S Lee, Lisa Johansen, Yanzhen Zhang, et al.
Molecular Systems Biology|June 10, 2010
Chemical combinations elucidate pathway interactions and regulation relevant to Hepatitis C replicationChristopher M Owens, Christina Mawhinney, Jill M Grenier, et al.
Blood|April 13, 2010
Adenosine A2A receptor agonists and PDE inhibitors: a synergistic multitarget mechanism discovered through systematic combination screening in B-cell malignanciesRichard J Rickles, Laura T Pierce, Thomas P Giordano, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 12, 2003
Systematic discovery of multicomponent therapeuticsAlexis A Borisy, Peter J Elliott, Nicole W Hurst, et al.
Nature Biotechnology|July 8, 2009
Synergistic drug combinations tend to improve therapeutically relevant selectivityJoseph Lehár, Andrew S Krueger, William Avery, et al.
Molecular Systems Biology|March 3, 2007
Chemical combination effects predict connectivity in biological systemsJoseph Lehár, Grant R Zimmermann, Andrew S Krueger, et al.
Molecular Cancer Therapeutics|April 5, 2012
Adenosine A2A and beta-2 adrenergic receptor agonists: novel selective and synergistic multiple myeloma targets discovered through systematic combination screeningRichard J Rickles, Winnie F Tam, Thomas P Giordano, et al.
Pageof 1